Kostas Manolis
Angel Investor @ Downing LLP
London, United Kingdom
Kostas Manolis is a post-ipo equity investor at Downing LLP in London focused on Health Care and Biotechnology. Kostas joined Downing as a Partner in 2015. He works across the Investment team and is a member of the Downing Ventures Investment Committee. He has more than 13 years’ private equity experience as investor, board director, portfolio manager, adviser and business angel. Kostas worked as a corporate finance advisor at PwC, where he advisedinstitutions and management teams on private equity deals and later joined the private equity team of Bank of Scotland in 2006. He was a member of the Caird Capital team that led a successful spin out of a £0.5 billion private equity portfolio from Lloyds Banking Group in 2010. Kostas has worked with management teams through operational improvement, growth, turnaround and successful exits. Kostas holds a degree in Biochemistry and a PhD in Molecular Genetics and is a Chartered Accountant with ICAEW.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Kostas Manolis invests in
Stages Kostas Manolis invests in
Countries Kostas Manolis invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 1 (50%)
- Biotechnology 1 (50%)
- Pharmaceutical 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Destiny Pharma is an innovative pharmaceutical company dedicated to the development of novel antimicrobial products.Our XF series of compounds have a mechanism of action that is fundamentally different from all existing antibiotics. As the likelihood of resistance developing is very remote, they offer potential advantages in controlling thedrug-resistant bacteria that are at the centre of a global healthcare crisis. | $24.7M / Post-IPO Equity / Dec 04, 2017 | ||
| Destiny Pharma is an innovative pharmaceutical company dedicated to the development of novel antimicrobial products.Our XF series of compounds have a mechanism of action that is fundamentally different from all existing antibiotics. As the likelihood of resistance developing is very remote, they offer potential advantages in controlling thedrug-resistant bacteria that are at the centre of a global healthcare crisis. | $20M / Post-IPO Equity / Oct 04, 2017 |
Co-Investors
About Downing LLP
At Downing, they aim to make a difference in the lives of their investment community. They design & manage investment products that help investors look after their financial wellbeing, while their investment partnerships support businesses in their ambitions. So far, over 35,000 investors have been a part of what they do, and they are proud to have raised and invested over £1.7 billion into businesses that make a difference, including renewable energy, care homes, health clubs, and children's nurseries. Downing is authorised and regulated by the Financial Conduct Authority.
Downing LLP Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Dan Quin
Head of Institutional Solutions
|
|||
James Weaver
Deputy CEO & COO
|
|||
Linda Bell
Non-Executive Director
|
|||
Nick Lewis
Founder
|
|||
Oren Laufer
Director of Institutional Sales
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Kostas Manolis invest in?
Kostas Manolis invests primarily in Health Care, Biotechnology and Pharmaceutical startups, most often at Post-IPO Equity stage. Most of the 2 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Kostas Manolis?
Public channels for Kostas Manolis include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Kostas Manolis last invest?
The most recent investment recorded for Kostas Manolis closed in Dec 2017. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
